BROWN ADIPOSE TISSUE ACTIVATION WITH MIRABEGRON ENHANCES FAT OXIDATION IN APOE*3-LEIDEN.CETP MICE AND HUMANS

被引:0
|
作者
Ying, Z. [1 ]
Van Eenige, R. [1 ]
Janssen, L. [1 ]
Berbee, J. F. P. [1 ]
Boon, M. [1 ]
Kooijman, S. [1 ]
Rensen, P. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
886
引用
收藏
页码:E99 / E99
页数:1
相关论文
共 50 条
  • [21] Both Transient and Continuous Corticosterone Excess Inhibit Atherosclerotic Plaque Formation in APOE*3-Leiden.CETP Mice
    Auvinen, Hanna E.
    Wang, Yanan
    Princen, Hans
    Romijn, Johannes A.
    Havekes, Louis M.
    Smit, Johannes W. A.
    Meijer, Onno C.
    Biermasz, Nienke R.
    Rensen, Patrick C. N.
    Pereira, Alberto M.
    PLOS ONE, 2013, 8 (05):
  • [22] Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice
    Liu, Cong
    Li, Zhuang
    Song, Zikuan
    Fan, Xiayue
    Shao, Hua
    Schonke, Milena
    Boon, Mariette R.
    Rensen, Patrick C. N.
    Wang, Yanan
    ATHEROSCLEROSIS, 2022, 362 : 47 - 55
  • [23] The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice
    Lisa R. Hoving
    Saeed Katiraei
    Amanda Pronk
    Marieke Heijink
    Kelly K. D. Vonk
    Fatiha Amghar-el Bouazzaoui
    Rosalie Vermeulen
    Lizette Drinkwaard
    Martin Giera
    Vanessa van Harmelen
    Ko Willems van Dijk
    Scientific Reports, 8
  • [24] FXR ACTIVATION NORMALIZES DYSLIPIDEMIA AND ALLEVIATES OBESITY IN WESTERN-TYPE DIET-FED APOE*3-LEIDEN.CETP TRANSGENIC MICE
    Paalvast, Y.
    Zhou, E.
    Mulder, N. L.
    Koehorst, M.
    Boverhof, R.
    van Dijk, K. Willems
    Rensen, P. C. N.
    Kuivenhoven, J. A.
    Kremoser, C.
    Wang, Y.
    Kuipers, F.
    Groen, A. K.
    de Boer, J. F.
    ATHEROSCLEROSIS, 2018, 275 : E10 - E10
  • [25] Mild Exercise Does Not Prevent Atherosclerosis in APOE*3-Leiden.CETP Mice or Improve Lipoprotein Profile of Men with Obesity
    Panhuis, Wietse In het
    Kooijman, Sander
    Brouwers, Bram
    Verhoeven, Aswin
    Pronk, Amanda C. M.
    Streefland, Trea C. M.
    Giera, Martin
    Schrauwen, Patrick
    Rensen, Patrick C. N.
    Schonke, Milena
    OBESITY, 2020, 28 : S93 - S103
  • [26] Treatment With Anti-pregnancy-associated Plasma Protein A Antibody Reduces Atherosclerosis in Apoe*3-leiden.cetp Mice
    Stokman, Geurt
    Pieterman, Elsbet J.
    Princen, Hans M.
    Kolumam, Ganesh
    Freund, Adam
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [27] ALTERNATING LIGHT-DARK CYCLES, BUT NOT CONTINUOUS LIGHT, AGGRAVATES ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN.CETP MICE
    Schilperoort, M.
    Van Den Berg, R.
    Bosmans, L.
    Van Os, B.
    Van Kerkhof, L.
    Dolle, M.
    Van Baarle, D.
    De Vries, M.
    Meijer, J.
    Biermasz, N.
    Lutgens, E.
    Rensen, P.
    Kooijman, S.
    ATHEROSCLEROSIS, 2020, 315 : E16 - E16
  • [28] The reduction of plasmatic VLDL-triglycerides by metformin is due to a specific augmentation of their clearance by brown adipose tissue in APOE*3-Leiden mice. CETP
    Geerling, J.
    van der Zon, G.
    van den Hoek, A.
    Princen, H.
    Havekes, L.
    Rensen, P.
    Guigas, B.
    DIABETES & METABOLISM, 2012, 38 : A29 - A29
  • [29] Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE∗3-Leiden.CETP Mice
    Inia, Jose A.
    Keijzer, Nanda
    Worms, Nicole
    van Nieuwkoop, Anita
    Ditmarsch, Marc
    Jukema, J. Wouter
    Kastelein, John
    Pieterman, Elsbet J.
    Princen, Hans M. G.
    AMERICAN HEART JOURNAL, 2024, 278
  • [30] Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE*3-Leiden.CETP mice
    Ying, Zhixiong
    van Eenige, Robin
    Ge, Xiaoke
    van Marwijk, Christy
    Lambooij, Joost M.
    Guigas, Bruno
    Giera, Martin
    de Boer, Jan Freark
    Coskun, Tamer
    Qu, Hongchang
    Wang, Yanan
    Boon, Mariette R.
    Rensen, Patrick C. N.
    Kooijman, Sander
    EBIOMEDICINE, 2023, 93